TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy https://t.co/HIYIEMPHDJ
792 followers
17,040 followers
Immunotherapy for cancer is improving patient survival. To increase the benefits, new strategies are needed. Externalized #Phosphatidylserine, a membrane lipid, can drive efferocytosis or engage PS receptors to promote immune suppression. Learn more here:
4,434 followers
Dr. Adam Dayoub & @brekkenlab @UTSWNews with @MethodistHosp Research Institute #PSON reviewed the development of antibodies targeting receptors on tumors to enhance #immunotherapy @BioMedCentral https://t.co/Pb00OBk6rh. https://t.co/nywtL7rzWG
118 followers
RT @antibody_worlds: TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapy. https://t.co/nk2jbFvYCG